Key facts
- This page summarizes Patrick Joseph Gallagher's Form 4 filing for BioSig Technologies, Inc. (BSGM).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 18 Aug 2023, 19:01.
Patrick Joseph Gallagher - 15 Aug 2023 Form 4 Insider Report for BioSig Technologies, Inc. (BSGM)
- Reporting relationship
- Director
- Issuer ticker
- BSGM
- Reported as of
- 15 Aug 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 18 Aug 2023, 19:01:36 UTC
- Prior SEC filing
- 20 Jun 2023
- Next SEC filing
- 18 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/Kenneth Londoner, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Patrick Joseph Gallagher filed Form 4 for BioSig Technologies, Inc. (BSGM) on 18 Aug 2023.
Change
- Previous filing in this sequence was filed on 20 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BSGM
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +12,000
- Change %
- +9.9%
- Price
- $0.000000
- Shares after
- 133,743
- Date
- 15 Aug 2023
- Ownership
- Direct
- Footnotes
- F1
BSGM
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,400
- Date
- 15 Aug 2023
- Ownership
- By Amy E Gallagher Educational Trust
BSGM
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,400
- Date
- 15 Aug 2023
- Ownership
- By Hans Gallagher Educational Trust
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The shares of restricted stock were granted in lieu of remuneration for the Company's 2023 second quarter board fees and shall be fully vested as of August 15, 2023, the date of the grant, based on a closing price of $0.6364 per share on such date.